101 related articles for article (PubMed ID: 21648092)
1. A three-dimensional colocalization RNA interference screening platform to elucidate the alternative lengthening of telomeres pathway.
Osterwald S; Wörz S; Reymann J; Sieckmann F; Rohr K; Erfle H; Rippe K
Biotechnol J; 2012 Jan; 7(1):103-16. PubMed ID: 21648092
[TBL] [Abstract][Full Text] [Related]
2. PML induces compaction, TRF2 depletion and DNA damage signaling at telomeres and promotes their alternative lengthening.
Osterwald S; Deeg KI; Chung I; Parisotto D; Wörz S; Rohr K; Erfle H; Rippe K
J Cell Sci; 2015 May; 128(10):1887-900. PubMed ID: 25908860
[TBL] [Abstract][Full Text] [Related]
3. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.
Fasching CL; Bower K; Reddel RR
Cancer Res; 2005 Apr; 65(7):2722-9. PubMed ID: 15805271
[TBL] [Abstract][Full Text] [Related]
4. A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas.
Henson JD; Hannay JA; McCarthy SW; Royds JA; Yeager TR; Robinson RA; Wharton SB; Jellinek DA; Arbuckle SM; Yoo J; Robinson BG; Learoyd DL; Stalley PD; Bonar SF; Yu D; Pollock RE; Reddel RR
Clin Cancer Res; 2005 Jan; 11(1):217-25. PubMed ID: 15671549
[TBL] [Abstract][Full Text] [Related]
5. De novo assembly of a PML nuclear subcompartment occurs through multiple pathways and induces telomere elongation.
Chung I; Leonhardt H; Rippe K
J Cell Sci; 2011 Nov; 124(Pt 21):3603-18. PubMed ID: 22045732
[TBL] [Abstract][Full Text] [Related]
6. DNA damage induces alternative lengthening of telomeres (ALT) associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNA.
Fasching CL; Neumann AA; Muntoni A; Yeager TR; Reddel RR
Cancer Res; 2007 Aug; 67(15):7072-7. PubMed ID: 17652140
[TBL] [Abstract][Full Text] [Related]
7. Telomere maintenance in Wilms tumors: first evidence for the presence of alternative lengthening of telomeres mechanism.
Venturini L; Daidone MG; Motta R; Collini P; Spreafico F; Terenziani M; Piva L; Radice P; Perotti D; Zaffaroni N
Genes Chromosomes Cancer; 2011 Oct; 50(10):823-9. PubMed ID: 21769957
[TBL] [Abstract][Full Text] [Related]
8. Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference.
Jiang WQ; Zhong ZH; Henson JD; Reddel RR
Oncogene; 2007 Jul; 26(32):4635-47. PubMed ID: 17297460
[TBL] [Abstract][Full Text] [Related]
9. The telomere-associated homeobox-containing protein TAH1/HMBOX1 participates in telomere maintenance in ALT cells.
Feng X; Luo Z; Jiang S; Li F; Han X; Hu Y; Wang D; Zhao Y; Ma W; Liu D; Huang J; Songyang Z
J Cell Sci; 2013 Sep; 126(Pt 17):3982-9. PubMed ID: 23813958
[TBL] [Abstract][Full Text] [Related]
10. PML3 interacts with TRF1 and is essential for ALT-associated PML bodies assembly in U2OS cells.
Yu J; Lan J; Wang C; Wu Q; Zhu Y; Lai X; Sun J; Jin C; Huang H
Cancer Lett; 2010 May; 291(2):177-86. PubMed ID: 19900757
[TBL] [Abstract][Full Text] [Related]
11. PML body meets telomere: the beginning of an ALTernate ending?
Chung I; Osterwald S; Deeg KI; Rippe K
Nucleus; 2012; 3(3):263-75. PubMed ID: 22572954
[TBL] [Abstract][Full Text] [Related]
12. HPV-16 E7 reveals a link between DNA replication stress, fanconi anemia D2 protein, and alternative lengthening of telomere-associated promyelocytic leukemia bodies.
Spardy N; Duensing A; Hoskins EE; Wells SI; Duensing S
Cancer Res; 2008 Dec; 68(23):9954-63. PubMed ID: 19047177
[TBL] [Abstract][Full Text] [Related]
13. Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination.
Draskovic I; Arnoult N; Steiner V; Bacchetti S; Lomonte P; Londoño-Vallejo A
Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15726-31. PubMed ID: 19717459
[TBL] [Abstract][Full Text] [Related]
14. A novel telomere structure in a human alternative lengthening of telomeres cell line.
Marciniak RA; Cavazos D; Montellano R; Chen Q; Guarente L; Johnson FB
Cancer Res; 2005 Apr; 65(7):2730-7. PubMed ID: 15805272
[TBL] [Abstract][Full Text] [Related]
15. Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1 complex.
Jiang WQ; Zhong ZH; Henson JD; Neumann AA; Chang AC; Reddel RR
Mol Cell Biol; 2005 Apr; 25(7):2708-21. PubMed ID: 15767676
[TBL] [Abstract][Full Text] [Related]
16. The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins.
Potts PR; Yu H
Nat Struct Mol Biol; 2007 Jul; 14(7):581-90. PubMed ID: 17589526
[TBL] [Abstract][Full Text] [Related]
17. [ALT--alternative lengthening of telomere].
Wu XM; Tang WR; Luo Y
Yi Chuan; 2009 Dec; 31(12):1185-91. PubMed ID: 20042385
[TBL] [Abstract][Full Text] [Related]
18. The F-box protein β-TrCP promotes ubiquitination of TRF1 and regulates the ALT-associated PML bodies formation in U2OS cells.
Wang C; Xiao H; Ma J; Zhu Y; Yu J; Sun L; Sun H; Liu Y; Jin C; Huang H
Biochem Biophys Res Commun; 2013 May; 434(4):728-34. PubMed ID: 23583392
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of telomeres and promyelocytic leukemia nuclear bodies in a telomerase-negative human cell line.
Jegou T; Chung I; Heuvelman G; Wachsmuth M; Görisch SM; Greulich-Bode KM; Boukamp P; Lichter P; Rippe K
Mol Biol Cell; 2009 Apr; 20(7):2070-82. PubMed ID: 19211845
[TBL] [Abstract][Full Text] [Related]
20. hRad21 overexpresses and localizes to the ALT-associated promyelocytic leukemia body in ALT cells.
Zhao B; Wang ZJ; Yi BQ; Ma HC; Xu HM
Cancer Biol Ther; 2010 Jun; 9(12):978-83. PubMed ID: 20364118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
